• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the mechanism by which extracellular vesicles miRNA induces abnormalities in tumor endothelial cells and development of novel cancer diagnostics and therapy

Research Project

Project/Area Number 16H06603
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Surgical dentistry
Research InstitutionHokkaido University

Principal Investigator

Torii Chisaho  北海道大学, 遺伝子病制御研究所, 客員研究員 (00780561)

Project Period (FY) 2016-08-26 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Keywords腫瘍血管 / 細胞外小胞 / miRNA / 薬剤耐性 / 腫瘍
Outline of Final Research Achievements

In this study, we investigated whether extracellular vesicles (EVs) involved in drug resistance in tumor endothelial cells. EVs were isolated from low and high metastatic tumor. We identified miRNA-X which was contained higher level in high metastatic tumor EVs than in low metastatic tumor EVs. miR-X was transported by EVs into endothelial cells and downregulated target gene Y expression. It induced drug resistance to 5-FU in endothelial cells. In the future, we will investigate whether miRNA-X relates to pathological factors and prognosis using clinical samples in order to develop novel cancer diagnostics and therapy.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Annual Research Report
  • Research Products

    (16 results)

All 2017 2016 Other

All Journal Article (8 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 8 results,  Open Access: 4 results) Presentation (7 results) Remarks (1 results)

  • [Journal Article] Aneuploidy of murine immortalized endothelial cell line, MS1.2017

    • Author(s)
      Hida K., Maishi N., Dorcas Akuba-Muhyia Annan, Kondoh M., Hojo T., Umma Habiba, Ohga N., Ishikawa K, Sato M., Torii C., Yanagiya M., Morimoto M., Hida Y., Shindoh M.
    • Journal Title

      J Oral Biosci

      Volume: 59 Issue: 1 Pages: 50-54

    • DOI

      10.1016/j.job.2016.10.004

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Vasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma2017

    • Author(s)
      Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y., *Hida K.
    • Journal Title

      Anticancer Res

      Volume: 37(3) Pages: 1219-1225

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity Show drug resistance2017

    • Author(s)
      9.Hida K, Maishi N, Akiyama K, Ohmura-Kakutani H, Torii C, Ohga N, Osawa T, Kikuchi H, Morimoto H, Morimoto M et al
    • Journal Title

      Cancer Sci

      Volume: 108 Issue: 11 Pages: 2195-2203

    • DOI

      10.1111/cas.13388

    • NAID

      120006373733

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Vasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma2017

    • Author(s)
      Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y., Hida K.
    • Journal Title

      Anticancer Res

      Volume: 37 Issue: 3 Pages: 1219-1225

    • DOI

      10.21873/anticanres.11437

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Aneuploidy of murine immortalized endothelial cell line, MS12017

    • Author(s)
      Hida K., Maishi N., Dorcas Akuba-Muhyia Annan, Kondoh M., Hojo T., Umma Habiba, Ohga N., Ishikawa K, Sato M., Torii C., Yanagiya M., Morimoto M., Hida Y., Shindoh M
    • Journal Title

      J Oral Biosci

      Volume: 59 Pages: 50-54

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tumor endothelial cells express high pentraxin 3 levels2016

    • Author(s)
      Hida K., Maishi N., Kawamoto T., Akiyama K., Ohga N., Hida Y., Yamada K., Hojo T., Kikuchi H., Sato M., Torii C., Shinohara N., Shindoh M
    • Journal Title

      Pathol Int

      Volume: 66 Issue: 12 Pages: 687-694

    • DOI

      10.1111/pin.12474

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Comparison of characteristics of mouse immortalized normal endothelial cells, MS1 and primary cultured endothelial cells2016

    • Author(s)
      Hida K., Maishi N., Torii C., Yanagiya M., Annan Akuba-Muhyia Dorcas., Morimoto M., Alam Mohammad Towfik
    • Journal Title

      Hokkaido Journal of Dental Science

      Volume: 37 Pages: 40-48

    • NAID

      120005855959

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tumor angiogenesis-characteristics of tumor endothelial cells.2016

    • Author(s)
      Hida K, Maishi N, Torii C, Hida Y.
    • Journal Title

      Int J Clin Oncol

      Volume: 21 Issue: 2 Pages: 206-212

    • DOI

      10.1007/s10147-016-0957-1

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Presentation] 高転移性腫瘍miRによる血管内皮における薬剤耐性誘導2017

    • Author(s)
      間石奈湖, 鳥居ちさほ, 川本泰輔, 森本真弘, 秋山廣輔, 吉岡祐亮, Alam Mohammad Towfik, 南 敬, 落谷孝広, 樋田泰浩, 樋田京子
    • Organizer
      第26回日本がん転移学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Correlation between endothelial CXCR7 expression and clinic pathological factors in oral squamous cell carcinoma (OSCC)2017

    • Author(s)
      Randa Ibrahim Dawood, Yanagiya M., Maishi N., Hida Y., Torii C., Kikuchi H., Ohga N., Tei K., Kitakura T., Shindoh M., Hida K.
    • Organizer
      第5回がんと代謝研究会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 高転移性腫瘍エクソソームmiRによる血管内皮の薬剤耐性誘導2017

    • Author(s)
      森本真弘,鳥居ちさほ,川本泰輔,間石奈湖,吉岡祐亮,落谷孝広,樋田泰浩,樋田京子
    • Organizer
      第5回がんと代謝研究会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Tumor endothelial cells acquire drug resistance by exosomal-miR derived from high metastatic tumor2016

    • Author(s)
      Hida K., Torii C., Maishi N., Morimoto M., Akiyama K., Kawamoto T., Minami T., Yoshioka Y., Mohammad Towfik Alam, Shindoh M., Hida Y., Ochiya T
    • Organizer
      The 19th International Vascular Biology Meeting
    • Place of Presentation
      Boston (America)
    • Year and Date
      2016-11-02
    • Related Report
      2016 Annual Research Report
  • [Presentation] 高転移性腫瘍エクソソームmiRNAは血管内皮のIL6を誘導し血管新生阻害療法への耐性を誘導する2016

    • Author(s)
      森本真弘, 鳥居ちさほ, 川本泰輔, 秋山廣輔, 間石奈湖, 吉岡祐亮, 落谷孝広, 柳谷美沙, 菊地 央, 北川善政, 鄭漢 忠, 進藤正信, 樋田泰浩, 樋田京子
    • Organizer
      第7回IGM研究交流会
    • Place of Presentation
      北海道大学(北海道札幌市)
    • Year and Date
      2016-10-18
    • Related Report
      2016 Annual Research Report
  • [Presentation] 高転移性腫瘍miRによる血管内皮におけるIL-6を介した薬剤耐性誘導2016

    • Author(s)
      間石奈湖,鳥居ちさほ,川本泰輔,秋山廣輔,吉岡祐亮,落谷孝広,柳谷美沙,森本真弘,菊地 央,鄭 漢忠,北川善政,進藤正信,樋田泰浩,樋田京子
    • Organizer
      第49回北海道病理談話会
    • Place of Presentation
      北海道大学 (北海道札幌市)
    • Year and Date
      2016-10-15
    • Related Report
      2016 Annual Research Report
  • [Presentation] 高転移性腫瘍miRによる血管内皮におけるIL-6を介した薬剤耐性誘導2016

    • Author(s)
      森本真弘,鳥居ちさほ,秋山廣輔,川本泰輔,間石奈湖,鄭漢忠,北川善政,進藤正信,樋田泰浩,樋田京子
    • Organizer
      第8回日本RNA-i研究会
    • Place of Presentation
      グランドプリンスホテル広島(広島県広島市)
    • Year and Date
      2016-09-02
    • Related Report
      2016 Annual Research Report
  • [Remarks] 北海道大学 遺伝子病制御研究所 フロンティア研究ユニット 血管生物学研究室ホームページ

    • URL

      http://www.igm.hokudai.ac.jp/vascular-biology/

    • Related Report
      2017 Annual Research Report

URL: 

Published: 2016-09-02   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi